UPM-Kymmene

Healthy Q3; there were some setbacks however

30/10/24 -"While UPM’s Q3 results were healthy – and largely Pulp-driven – they fell short of the market’s expectations. Perhaps the biggest disappointment was the group-level demand recovery ..."

PDF page sample
Pages
52
Language
English
Published on
30/10/24
Download
You may also be interested by these reports :
11/02/26
Besides the moderation of earnings, the target price has also been impacted by the somewhat lower value of forests – which impacts both the DCF and ...
04/02/26
2025 ended on a reassuring note for UPM-Kymmene, with Q4 profit ahead of consensus expectations. Even though 2025 results were restrained, management ...
04/02/26
Even though Stora’s Q4 results were soft and its turnaround is delayed, Forest division is proving to be a big and valuable differentiator. Besides ...
30/01/26
Q4 results were soft and missed street expectations. While Forest witnessed sizeable moderation, the division remained healthy and was well supported ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO